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Background: Drug misuse is an important clinical problem associated with a poorer outcome in patients who
have a diagnosis of schizophrenia. Qualitative studies have rarely been used to elicit reasons for drug use in
psychosis, but not in schizophrenia.
Methods: Seventeen people with a diagnosis of schizophrenia and who had used street drugs were interviewed
and asked to describe, in narrative form, their street drug use from their early experiences to the present day.
Grounded theory was used to analyse the transcripts.
Results: We identified five reasons for continuing street drug use. The reasons were: as an ‘identity defining
vocation’, ‘to belong to a peer group’, due to ‘hopelessness’, because of ‘beliefs about symptoms and how street
drugs influence them’ and viewing drugs as ‘equivalent to taking psychotropic medication’. Street drugs were
often used to reduce anxiety aroused by voice hearing. Some participants reported street drugs to focus their
attention more on persecutory voices in the hope of outwitting their perceived persecutors.
Conclusions: It would be clinically useful to examine for the presence of the five factors in patients who have a
diagnosis of schizophrenia and use street drugs, as this is likely to help the clinician to tailor management of
substance misuse to the individual patient’s beliefs.
Background
Illicit drug use is common in schizophrenia. Reported
prevalence rates vary, for instance, in a recent study
11.9% of people with schizophrenia had comorbid drug
abuse or dependence [1]. A recent meta-analysis showed
about 1 in 4 patients with schizophrenia had cannabis
use disorder [2]. This is up to five times higher than in
the general population [3] and results in higher rates of
relapse, hospitalisation, suicide and other adverse out-
comes [4]. The reasons for this comorbidity are complex
and a number of competing theories have been gener-
ated and studied using quantitative methods [5-8].
Reviewers have sought to evaluate the degree of empiri-
cal support that exists for each theory [6,9]. Psychosocial
factors appear to be important in maintaining substance
use in this population [5,6,8,9] and a thorough assess-
ment of psychosocial factors is important in engagement
and tailoring interventions [5,6,10]. To answer the ques-
tion as to why this client group uses substances, it
makes sense to discuss this directly with service users
[4,11]. From the quantitative literature, self reported fac-
tors which may account for drug misuse in schizophre-
nia have been summarised: to achieve intoxication, to
enhance ability to socialise with others, to self-medicate
for positive and negative symptoms of schizophrenia
and to relieve dysphoric mood; in the case of cannabis
but probably not other substances, the cannabis use
itself may have precipitated the schizophrenia in vulner-
able individuals [6]. Quantitative self report studies have
been very useful but may fail to discover some impor-
tant reasons for drug use in schizophrenia because the
questions posed are fixed in advance of any data collec-
tion. By contrast, a number of qualitative methods
involve constantly analysing the data as it is collected
and adjusting the questions posed so that the researcher
can refine the questions to test out new concepts in
subsequent interviews [12-14]. Novel reasons for phe-
nomena, uncovered using qualitative methods, can later
be tested in larger groups using quantitative methods.
* Correspondence: Linda.Gask@manchester.ac.uk
2School of Community Based Medicine, University of Manchester, NPCRDC,
5th Floor, Williamson Building, University of Manchester, Oxford Road,
Manchester UK
Full list of author information is available at the end of the article
Asher and Gask BMC Psychiatry 2010, 10:94
http://www.biomedcentral.com/1471-244X/10/94
© 2010 Asher and Gask; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.To this end, two qualitative studies in the United
Kingdom (UK) have recently looked at reasons for
drug use in patients with psychosis [15,16] and a study
in the United States of America (USA) has looked at
attitudes to substance use in a mixed group of patients,
some of whom used drugs [17]. A further UK study of
reasons for drugs and alcohol use in people with schi-
zophrenia used mixed methods including what appears
to have been a very small semi-structured interview
study and a descriptive analysis of tapes of therapy ses-
sions (the method was not well described) to develop
questions which were then posed to a larger group and
factor analysed [18]. These studies have found that rea-
sons for drug use were: to relax and improve social
p e r f o r m a n c e[ 1 5 , 1 8 ] ;t ob e l o n ga n ds h a r ei nag r o u p
experience [15]; to avoid losing a peer group [15]; to
achieve intoxication [15,16];t or e d u c es i d ee f f e c t so f
medication [16]; to reduce aggression [15,16]; to cope
with distressing emotions and positive symptoms [18];
to feel powerful/creative [16,18]; to cope with trauma
or loss [15,16]; to achieve a sense of identity and social
status, escaping a dull life [15,16]; because drugs were
not believed to cause psychosis [16]; because the pre-
ferred substance was more acceptable in the hierarchy
of acceptability of drugs [15]; because cannabis had
been used long before onset of psychosis and was nor-
mal in their community [15,16]; because cannabis was
like a medicine [16]. Examples were found both of
patients who thought that drug use had been a factor
in precipitating and relapsing mental illness and
patients who denied any adverse impact on mental
health [15-17]. Reasons for attempting to not use drugs
were because of negative effects on mental state [16];
cost and illegality [16]; to improve health, finances and
family relationships [15].
It remains unclear however whether the results of
qualitative studies of reasons for drug use in psychosis
would be applicable to the narrower sub-group of peo-
ple with schizophrenia; thus our study looks specifically
at reasons for drug use in schizophrenia.
The aim of this study [19] was to elicit reasons why
some people who have a diagnosis of schizophrenia
repeatedly use any street drugs, using a qualitative
methodology so that novel reasons could emerge and




Qualitative study carried out with people with a clinical
diagnosis of schizophrenia. Ethical approval was
obtained from Bolton Local Research Ethics Committee
(LREC) and subsequently from Central Manchester
LREC, reference numbers 02/BN/704.
Participants
Participants were people from two socially deprived
areas of Greater Manchester, an inner city area and a
smaller town within the conurbation. All had a diagnosis
of schizophrenia, used substances and were known to
local psychiatric services. Participants were not under
the clinical care of either of the researchers. Participants
of diverse demographic (age, sex, ethnicity) characteris-
tics were sought in order to obtain a maximum variation
sample [13]. We approached all consultant psychiatrists
in these services asking them to identify all service users
who met our inclusion criteria. Recruitment and initial
contact with the patients was by an opt-in letter sent on
behalf of and with the agreement of their own consul-
tant. We sought to recruit all those who met our inclu-
sion criteria and were female or of Black Minority
Ethnic (BME) groups; we recruited as many white male
participants as were necessary to reach saturation of
data (see below). To compensate for the difficulty we
encountered in recruiting female clients and people
from ethnic minorities, such patients were purposively
sought by identifying potential interviewees from these
groups and repeatedly requesting consultants to pass on
opt-in letters to these patients in particular.
Interviews
We asked individuals to describe in narrative form their
history of drug misuse and mental health problems
from earliest experiences, moving forward in time to the
present, with concurrent descriptions of their social
context.
We wrote an initial topic guide based on the literature
as follows:
◦ “What substances have you ever used?
◦ Tell me about when you first started using
substances.
▪ What was life like at the time?
▪ What effects do you get from each substance?
◦ Tell me about how your substance use has been
over time since then.
▪ What has life been like?
◦ How have you been in yourself?
▪ Does anything help with that?
◦ What are your opinions of different street drugs?
◦ Why do you think that people who have psychosis
would carry on using substances?”
The interview covered items in the ‘topic guide’ and
any additional material spontaneously suggested by the
patient. We adapted the order and style of questions at
each interview in response to cues from the participant.
To gain the maximum information, all participants were
encouraged to give their own detailed personal account
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with minimal prompts from the interviewer, including
any associated memories or ideas that were meaningful
for the participant. The interviews were for as long as it
took for the participant to tell their story or as long as
the participant could tolerate, hence they ranged from
approximately 40 minutes to 2 1/2 hours. They were
provided with snacks and could take breaks if desired.
Analysis
All interviews were recorded, transcribed and anon-
ymised. The transcripts were analysed utilising
Grounded Theory [14]. We read each transcript and
added meaningful labels or ‘codes’ against words or
phrases that were relevant to possible reasons for illicit
drugs use. We constantly compared codes within and
between interviews and condensed similar codes
together. We analysed the data whilst we continued to
carry out more interviews, adapting our topic guide as
the study progressed. At all stages of the analysis, we
compared our emerging ideas about reasons for drug
use with the interview transcripts and we discarded any
ideas if the data did not support them. We wrote lists of
codes for each participant (’open coding memos’)i n i t i -
ally grouping the codes according to descriptive head-
ings of which substances were used, how they were
used, any unusual incidents, the individual’s life/relation-
ships and perception of self. We compared these lists
between participants to look for meaningful groupings
of codes or ‘categories’ and wrote ‘theoretical memos’
about possible causal links between categories. Our the-
oretical memos included inductively writing a ‘story line’
or composite of the interviewees’ stories of their street
drug use and constructing a wall chart of the data to
look for emergent patterns [20]. Wherever we found
that the 17 participants could be divided into two or
more groups according to a characteristic relevant to
drug use, we closely examined how the groups com-
pared and contrasted to explore why these differences
occurred.
We continued recruiting subjects and analysing inter-
views until we had reached saturation of the data, in
that there were no new themes emerging and we had
tested all the categories for disconfirming cases and
variations.
Results
Forty-five people were sent opt-in letters, of which 27
agreed to receive further information. Of this 27, 17 par-
ticipated (see Table 1), one did not supply contact
details, one was unable to consent due to acute psycho-
tic illness, three declined without giving a reason and
five declined, stating that they felt unwell.
To compensate for the difficulty in recruiting female
clients and people from ethnic minorities, such patients
were purposively sought by identifying potential inter-
viewees from these groups and repeatedly requesting
consultants to pass on opt-in letters to these patients in
particular. We specifically sought these groups (with
some success - see table 1) in order to get as near as
possible a maximum variation sample and hence make
our findings more generalisable.
In reviewing our ‘theoretical memos’, the most fruitful
comparisons appeared to be between those who
intended to abstain in the future and those who pre-
ferred to continue street drug use.
We identified five key reasons for street drug use in
schizophrenia. Drugs were used:
￿ As a identity-defining vocation
￿ To belong to a peer group
￿ Due to feelings of hopelessness
￿ Due to beliefs about symptoms and how street
drugs influence them
￿ As an equivalent to taking psychotropic medication
Drug use as an identity-defining vocation
Like a vocation, the activity of substance use was often
acquired in youth and developed with increasing knowl-
edge and skill over time, providing a sense of identity, a
social activity and enhanced self-esteem through mastery
of a subject.
Almost all participants first tried illicit substances in
their teens and fifteen had commenced drug use before
developing mental health problems. Just as hobbies are
often thought of as ‘keeping young people out of trou-
ble’, some believed that cannabis use was protective
against use of drugs such as heroin or indeed against
use of excessive alcohol.
Table 1 Characteristics of participants: N = 17
Gender
Male 16 Female 1
Age
16-19 1 30-34 1
20-24 4 35-39 10
25-29 0 >40 1
Ethnicity
White 13 African 2
African-Caribbean 1 Asian 1
Current illicit drug use
Using 12 Abstaining 5
Street drugs used
Only cannabis 3 Multiple but mainly cannabis 6
Mainly stimulants 6 Mainly opiates and stimulants 2
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injected amphetamines and used LSD and cannabis
heavily, gave up drugs for a partner and became alcohol
dependent; he said:
“They didn’t realise I was taking overdoses and things
like that. Because every time I took an overdose, it was
paracetamol, 100 at a time. Where’s the life gone. “I’m
not a piss head [alcoholic] what have I done? Dad’sa
piss head, mum’s a piss head. I’maj u n k i e[ d r u g
addict], where’sm yd r u g sg o n e ? ” All the drugs gone
out of my life. I was f***ed up in my head because I
was on a different way of life.” (Participant 1).
He went on to describe drug related aspects of his
identity that he felt were positive and that he had
decided he could retain despite abstinence by convin-
cing himself that the drugs literally remained inside him
long term like an “everlasting gobstopper“ [fictional chil-
dren’s confectionery]. When the interviewer asked him
why, he said:
“Because [pause] when I was a teenager, people out
there, the society, people popping e’s [ecstasy], having
ab i to fC h i n a[ h e r o i n ] .It e l lt h e mt ot h e i rf a c e ,I
say, “f*** you’re head up, I’ve done it before I don’t
want it.”“ You keep taking that”, I was telling some-
one, I’m a big grass[sneak], f***them. “Listen to me
what I’ms a y i n g ”. Like on bus-stop, on way home
from Manchester this afternoon, couple of lads. I’m
there, the famous laddy [boy]. The “mad junkie”.I
got a lot of friends. I was at the bus stop and there
was a lad [boy] there talking about something. I
knew what he was on about, he wanted to know
about this that and the other. Said, “h o wd oy o ud o
this and how do you do that?”, these things, drugs.
“What’s best to take?” Is a i d ,“don’t take any more”.
Al a dn e x tt om e ,Is a i d“look am I happy? I’m
f***ing straight [off drugs], I’m not a ‘mad’ you know,
just ‘f***ing mad’.” To prove to him, I said, “don’t
bother taking drugs and tell all your mates in [sub-
urb] don’t bother taking them either”. But he said, “I
want to do it”. But he who laughs last laughs last.
Me and my friend [name], before he left me,, we was
injecting speed. We would do a lot of injecting, a lot.
Before he died. About 6 or 7 years back. We left off,
we was in a night club in Preston, the [name], you
been there? It’s hardcore [good]. We left each other.
We’re twins, best mates, always together, solid to the
world.” (Participant 1).
When the interviewer asked if he meant they were
encouraging each other to take more drugs, he replied:
“We were like fanatics, like professional whizz heads
[users of amphetamine]. Professional whizz heads.
W ed i di t ,w ed i di t .N e v e rs t o p p e df o ras e c o n do f
the day. We’ds l e e pf o r4d a y s .I nb e df o r4d a y s .
Sleep 4 days gone, no bullshit [lie]. Valium [diaze-
pam] 15, 20 mg, temazepam as well. Bed for 4 days.
I’d not seen him, about 8 month after, he started
dying of angina of heart attack and died. He, he
died. Swine he was.” (Participant 1).
Most felt that they had a lot of knowledge and experi-
ence of drugs. As expressed in the quote above, drug
use was an important part of their identity.
The majority had started with cannabis and then tried
other drugs. A British Asian Muslim man in his thirties
who mainly used amphetamine (by mouth) explained:
“I’ve tried whole range of them really since I was a
teenager. started off with cannabis to begin with then
it moved higher and higher to, acid tab, ecstasy, blue
a n da l lo ft h a t ,et a b l e t sc o m eo u ta n do nt h e m .
Amphetamines as well. So carried on with the whole
range of them, but I didn’t like the cannabis I didn’t
like cannabis. I preferred the uppers [stimulants]
rather than downers [depressants], but started taking
some of the uppers. It was really one at a time. I’ve
quit it all now, it got too much for me over the years,
amphetamines.” (Participant 16).
Cannabis use was often seen as ‘normal’ among older
people that they looked up to when they were teenagers,
including elder brothers and sometimes parents. The
same participant explained how he had first experimen-
ted with what he thought was his father’s cannabis:
“Well someone in my school, a boy [name] he’s the
one who found some. My dad used to smoke it and I
found a piece of my dad’sb u ti tw a s n ’tr e a la tt h e
time, a real piece, but he asked me to make him
some joints [cannabis cigarettes] out of that.” (Parti-
cipant 16).
Similarly, a man in his early 20 s of African descent,
who used mainly cannabis and alcohol, but also opiates,
LSD, cocaine, amphetamines and benzodiazepines said:
“One time [my mum] had to be admitted into hospi-
tal, so for three weeks my brother was looking after
us in the house. So we had all these friends in and, I
remember my brother was really protective of us then
and he had his friends smoking buckets [cannabis
apparatus], smoking cannabis in the house. And he
wouldn’t let me go near it. But on other instances
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they used to save me some cos I was [his] little
brother. look after me that way.” (Participant 3).
For sixteen interviewees, substance use had been the
main leisure activity or an essential part of their life for
much of their adult lives, although four of these had
stopped using substances at the time of the interview.
Four described having a kind of ‘connoisseurship’ of sub-
stance(s), in the sense of having in-depth knowledge of
the varieties of a substance and technical aspects of
these. A white male in his late 30 s, who regularly uses
cannabis, including to relieve anxiety and to feel more
musical and who had not lived up to parental academic
expectations, described how to make a cannabis cigarette:
“ If you heat it, it expands, but in a lot of places in
the world, they’ll frown upon you for heating it
because it burns off the top notes, um so with
‘Squidgy Black’[a type of cannabis] you could just
roll it into a sausage and drop it in and that was
pretty incredible.” (Participant 4).
All but three interviewees clearly described a hierarchy
of acceptability of substances, including one patient who
had been dependent upon heroin. In this hierarchy, can-
nabis was seen as acceptable, whilst crack cocaine and
heroin were least acceptable. Cannabis use was some-
times seen as protective against use of other substances.
Another white male participant in his late 30 s who had
used alcohol, solvents, pills, poppers and glue, and had
tried but disapproved of heroin, amphetamine and
cocaine, said that it was helpful to decide that he pre-
ferred cannabis:
“...It’s better, if you are on [using] something, because
you are not tempted to be on what they are on. If
you are with your friends and you state your case
that you don’t touch that...” (Participant 6).
To belong to a peer group
Substance use also offered a sense of belonging, which
appeared from the data to be both highly important for
the individual but also conditional upon continued sub-
stance use and greater efforts to fit in. For almost all the
interviewees, (15 out of 17) beginning to use substances
was like a rite of passage, as if to mark the joining of a
community. Participant 6 described above, who said he
preferred cannabis, described vividly the sense of
togetherness enjoyed through substance use:
“Sometimes when everyone’s that tied up, this is my
experiences, everybody can sit in a room and there’s
drugs on that table, right so we all take the drugs
that we decided. Now he’s worried he might o.d.
[overdose], pop his clogs, [laughs] he’s worried that he
might o.d. Now all the time we’re comforting each
other, talking to each other, on this drug, talking peo-
ple round ‘because we’ve not been given it off the doc-
tor, it’s come off the street. And all the time even
though we’re laughing and enjoying a joke, each one
is holding each other up all the time, looking out for
[protecting] each other, it’s just natural. Really strong
men and their weaknesses, because it makes them
feel weak, they don’tk n o wi fi t ’sg o i n gt op o pt h e m
off, so then they’re all comforting each other and
eventually it gets to a point where everybody is okay
and everybody will start breaking off, wandering up
there or coming back, that’s what’s so good about it”.
(Participant 6).
Participants said they had been urged to use drugs by
friends or, more usually, that patients sought substance-
using peers. However all had persistent difficulties with
social interaction. Reasons included being distracted by
hearing voices or experiences of their thoughts being
interfered with, having lack of drive to socialise, anxiety or
low/irritable mood, feeling stigmatised and being preoccu-
pied with unusual interests or experiences. Eleven out of
17 interviewees described how drugs helped them to mix
and talk to others. Some said drugs only helped them to
mix with people who also used drugs. Indeed sometimes
drugs made it harder for people to mix with people who
didn’t use drugs. A white male in his mid thirties who said
he was given amphetamines age 16 by his elder brother
and who continued to use with this relative said:
“No I don’t usually see anyone or hang about [associ-
ate] with anyone who doesn’tt a k et h e m ,Id o n ’t like
people’s attitudes, you know I’ms o f tm eI ’mv e r y
kind at heart so I only like hanging about with peo-
ple who understand me.” (Participant 13).
However giving up drugs would mean, for some, hav-
ing to lose their friends and twelve people reported that
they felt they had to continue to use drugs in order to
keep their groups of friends. For example Participant 6
who now preferred cannabis, explained that he needed
to use cannabis when with peers and would come under
pressure to experiment with ‘pills’:
“...If you are with your friends and you state your
case that you don’t touch that but you want to be
friends with them, then my mate used to come back
and say that they had sorted you out [bought you]
some tablets for tonight, you can have a laugh [good
time]. ‘Becauseit’s no good being with everybody I
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can’t have a laugh because, they’re on a different
level.” (Participant 6).
Many said that they had been taken advantage of. This
included getting into debt with drug dealers and giving
drugs away. Self esteem was experienced as higher in
the context of the subculture of substance-use as com-
pared with in mainstream society. Participants could be
seen as one of the gang, heroes who had bravely saved
others from danger, wise elders, connoisseurs, admired
risk takers, intrepid explorers of the mind, entrepreneurs
or generous sharers.
There was strong evidence of people hiding their hear-
ing voices from their substance-using peers for fear of
being labelled as ill, but it appeared that such peers were
more tolerant of the types of unusual experiences as
might be explained away as being due to substance use.
In contrast, some reported that if they did begin to have
experiences beyond what their peers judged to be typical,
they would be informed in a helpful way. A white male in
his thirties who regularly used intravenous ampheta-
mines, sometimes used cannabis and had tried heroin,
explained that after his first episode of schizophrenia, his
old friends had abandoned him, whereas people who use
drugs “care about one another their well being“,t h e yh a d
visited him in hospital, they enquired how he was and he
believed most of them had experienced “paranoia“.
“...They can handle it [pause] when I’ve been para-
noid, when I’ve been on drugs, I’ve been paranoid,
they say like, ‘stop taking drugs, you’re paranoid,
you’re ill’”. (Participant 5).
This individual blamed his substance use on the men-
tal health services for ‘introducing’ him to people who
use substances and assuming that he did too.
Feelings of hopelessness
Areas of their lives about which some felt hopeless
included relationships with partners, family and friends,
acceptance by the wider community, employment pro-
spects and accommodation. Where participants were
optimistic about improvements in these aspects of their
life, and if they saw substance use as a potential barrier
to something that was otherwise attainable and strongly
desired, then they spoke of being prepared to give up
substances.
A white male in his late thirties who used heroin,
crack cocaine, amphetamine and cannabis, said he had
decided to abstain from opiates and stimulants in the
hope that he might gain employment and resume con-
tact with his daughter:
“...But when she’s older she’s going to have to look at
me as a father figure and then I’m going to have to
have qualifications behind me so I can show her-
something, so a mechanics course or somethinglike
that. And welding courses, so I can communicate
properly with her so she can look and say ‘oh my
dad’sam e c h a n i c ’ or ‘my dad’s a computer control-
ler’. Not just a drop out.” (Participant 8).
Loss of loved ones was commonly mentioned. Four
described at least one significant bereavement, and six
reported having experienced a prolonged rejection by
their relatives at some point in their lives. Twelve
reported losing friends or girlfriends, due to rejection in
the context of developing symptoms or continued sub-
stance use or more rarely because of deaths due to sub-
stance use. Most participants said they felt somewhat
outside of society. A whitem a l ei nh i st w e n t i e sw h o
preferred cannabis but when younger had used a wide
range of other substances had a girlfriend but was
unable to retain work due to persecutory voices:
“Id o n ’t see my family very often, I don’th a v ea n y
friends, there is no real good things“ (Participant 7).
Participant 6 (described earlier) who had had a diffi-
cult middle phase of his life in which he had switched
from drugs to alcohol and felt he had to ‘get violent’ to
access mental health services, but was an inpatient at
the time of interview, described use of cannabis to remi-
nisce about lost relationships:
“I use it more as a comforter now as I’ve got older,
but more for just mucking around [recreation].
What makes people keep using substances? That’s
one of the main things I can think of. The other
thing is, with me it takes me back to my childhood.
Some people might get sores done in [injured] by
society and they need something that’ll shut the
body down for a while. So they might get their head
back together because they feel so horrible or feel so
poorly or they’re being victimised by society or
something. They take it just to, [have a] quiet life.
It’s just like going on holiday, a cheap holiday! Who
gives them a break, then hopefully you’ll wake up in
morning and you’d be ready to take on the world”
(Participant 6).
Many had thought about stopping drugs so that their
lifestyle would be more stable. An Asian male partici-
pant in his thirties described how in the past he did not
fit in with cultural expectations including of working,
but that he believed that his abstinence from stimulants
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married:
“,,,,,I ’d like to get married at the end of the year
and then move.” (Participant 16)
He went on to say that his main incentive to remain
abstinent was that it would enable him to buy his own
house, (his family home is difficult due to mental illness
in elders and drug dealing siblings). However the initial
stimulus to abstain had been concerns for his physical
health:
“Well it got too much for me really, I’m getting older
and, if I don’t let go of it now, then it’sg o i n gt ob ei n
my system and it’s going to get a bit too much tricky
on the heart.” He continued, “All the power in you, so
that amphetamine makes your heart pound faster. So
you’re not supposed to have anything make your heart
pound faster when you’re older”. (Participant 16).
Others preferred to continue using substances and did
not wish to seek regular employment, although some con-
tinued using drugs because they believed drugs helped
them to carry out certain tasks, such as artwork, music,
study, muscle building exercises and household chores.
Some aspired to goals that seemed difficult to achieve in
the hoped-for timescale. Examples included working in
USA, being able to afford to driving lessons and a car on
limited savings, or of starting in highly skilled jobs. It was
difficult to establish in the interviews why they had settled
upon such goals, as any challenge to these seemed to threa-
ten rapport, but there was some suggestion that they felt
entitled to a better standard of living but had limited experi-
ence of working steadily towards realistic goals. There was
some evidence that having unrealistic plans might lead to a
cycle of abstaining in the hope of some reward, but when
that was not achieved, being very disappointed and rapidly
resuming substance abuse to cope with the feelings. In two
participants’ interviews there was an example given of using
drugs when high hopes or expectations were disappointed.
There was use of substances simultaneous with experien-
cing disappointment in a further eight.
Explaining about his recent frustrations with not yet
being provided with independent accommodation to
move on to, Participant 1 described above (white male,
late 30’s) said:
“They’re not doing anything for my life I’ve got to do
something about it now. Try a bit of whizz [ampheta-
mine]. See what happens”. (Participant 1).
Being in very poor accommodation occurred at some
stage in the lives of twelve out of the seventeen
interviewees. Some participants reported that being in a
hostel had resulted in being a victim of crime or other
adversity and using drugs to cope. Eight participants
reported an episode of problematic accommodation,
such as a hostel, during which they had escalated their
substance use, in terms of quantity and types of sub-
stances used.
Beliefs about symptoms and how street drugs influence
them
Those who believed that they were not psychotic and
that street drugs did not usually have a deleterious effect
on their mental state were less likely to be amenable to
abstaining. 13 out of 17 participants currently regarded
much of their voice hearing and other unusual experi-
ences as real. Such experiences were often of a religious
or persecutory nature. A white female in her late 30 s
who used mainly cannabis (to control anger) and
amphetamine (to cope with unusual experiences),
explained about her use of amphetamine:
“It helps me fight my abusers off and if my abusers
get too heavy; I’ve been having illegal operations and
all sorts happening to me. Now these operations are
not ordered by medics at this hospital or even my
doctor at this hospital. There has been an illegal
operation done on me only a few days ago while I
was pregnant which could be due to the fact that I
could miscarry. These operations are due to a child-
hood abuser of mine getting in to the surgical realm,
studying surgery as he got older and operating on
me, he’s been operating on me since I was about
18,19 and he’s done some nasty operations on me,
but he is no longer a problem.” (Participant 12).
Sometimes medical labels were used to describe dis-
tress, but in most cases, interviewees’ meanings of such
term were very different to the DSM IV definition. For
instance, Participant 6 defined ‘psychosis’ as “a feeling of
paranoia, um feeling like the world’s racing by faster“.
Participant 7 described above, who intended to continue
use of drugs, believed that incidents of (ordinary) curios-
ity about sexuality as a child had resulted in “schizophre-
nia“, by which he seemed to mean anxiety due to ‘real’
persecution by others who had misunderstood his beha-
viour:
“Because I’ve grew up with schizophrenia, well I’ve
grew up with people thinking I’m some sort of sexual
menace, that’s my degree of schizophrenia, I’ve grew
up with people thinking I’ms o m es o r to fs e x u a l
menace, when really I’mn o t ,i fa n y b o d yr e a l l yk n e w
that they would know I’m the sweetest guy and I
would never hurt anybody, and I really mean that,
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philes out there that think well to touch somebody
up a little bit doesn’t really hurt them, it does,, and I
would not lay my hands on anybody and touch them
up, but there’s just so many people questioning me, I
question myself” (Participant 7).
Twelve did not believe that substances had a consis-
tently negative impact on the severity of voices or pre-
occupation with unusual beliefs. Such views were
mainly based on experience and sometimes because
voices were believed to be real and external to self. A
white male in his thirties who was currently using can-
nabis (but had tried gas and solvents), explained that he
had initially blamed his voices on cannabis, but had
subsequently experienced a worsening of the voices
whilst abstaining and so had decided to resume use to
cope with his anxiety.
“...after about a couple of weeks the voices got stea-
dily and constantly worse, even though I wasn’t using
drugs whatsoever and I thought to myself, well I was
relieved a little bit when I was on the weed so I went
back on it and I just relaxed then and made me able
to cope with the voices a bit better” (Participant 14)
Two stopped using cannabis after they began to hear
voices; of the remaining participants, nine had mainly
enjoyable/grandiose voices and six had voices that were
distressing but modifiable with substances. Four had
unpleasant voices but chose to use substances to attend
more to these voices rather than try to blot them out. In
the following two examples, amphetamine was used for
this purpose. A white male in his thirties who was living
in supported accommodation and used multiple sub-
stances including opiates, stimulants and cannabis
described the effect he hoped for from amphetamines:
“I just get chatty to the voices talk to them, talk
about processes and about the book I’m writing, you
know, about the science fiction book I’mw r i t i n ga n d
the processes what I’ve been taught, through hypnosis.
You know, that’s what they’re after, see and I won’t
give them them.” He went on to explain that it was
risky to be ‘chatty’ with the voices. “Ig oa g a i n ,‘you
talk a load of crap, as far as I’m concerned, you
never tell me anything’ and they’re always trying to
control me. And I was trying to find out about the
‘special forces’ implants what they put in my head
when they make me safe. Which means so I can’tb e
hypnotised [deep breath] you know. [Cough] But I
can’t say much else, you know because I think they’re
listening in to our conversation“ (Participant 8).
Participant 12, described above (late 30 s female), said:
“I do take amphetamines every now and again, now
amphetamines I do use on the odd occasion when
I’m having to stay awake because of expecting influ-
xations [the arrival] of abusers.” She continued. “So
it’s a false energy burst basically and really I use
that to manipulate my body in to staying awake so
that I can deal with any abusers that might hurt
me.” She continued. “It involves me getting a bit
r o u g hw i t hm ya b u s e r s ,b u tI ’ve learnt a crafty way
of doing it. At the moment in the psych ward, it’sa
very unusual psych ward that I’m on, it’s actually got
an electric roof and the abusers have actually been
going in the roof and down through the ceilings and
abusing people and I go on the roof and I collar
[grab] them on the roof and I actually do use the
electricity on them to stun them, so the police and
army can arrest them.” (Participant 12).
Amphetamine use was repeatedly described as conco-
mitant with unusual experiences, but was seen at the
time as raising alertness to engage fully with the experi-
ences, rather than the amphetamine causing hallucina-
tions. A white male in his thirties who was now
abstaining said:
“I just wanted to be out of my head, it was like,
with my psychosis, the more I was out of my head
the more I was in touch with mental illness. the
quicker my mind was my metabolism obviously
speeds up my mind thinking quicker and this thing
that was going on in my head I wasn’ts u r ei fi t
was real or make believe or just illness know. But I
knew I had to be alert you know to get myself
through it and I mean I’ve been there and I’ve been
in hospital and I’ve actually visually and audibly
with my hands created the universe just in my
mind, but seeing it in front of me as if I was a god.
I’ve created this universe, well a galaxy it was, spin-
ning yes and things like that. And I thought that I
had to have this amphetamine to keep me on that
level”. (Participant 17)
By contrast, five people said that cannabis could allow
them to let the voices wash over them without causing
distress, including this white male in his thirties:
“I just treat it as um just sit back and relax and
sort of go with the flow sometimes, I’ll hear the
voices and I’ll go “yeah, yeah, yeah carry on, yeah,
yeah, yeah carry on I don’t care what you say."”
(Participant 14).
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increase in some unusual experiences or beliefs, ten par-
ticipants intended to continue their use in future. Rea-
sons given by these ten were that only a specific drug or
bad batch was to blame for the experiences (seven), that
only some experiences are caused by substances (nine)
and that street drugs allowed better coping with these
voices/beliefs (ten participants).
An example of an adverse incident with drugs being
blamed on a contaminated sample and drug use conti-
nuing or even escalating thereafter came from a white
male in his thirties who used amphetamine from age 17
(with his elder brother):
“W h e nIw a s2 1Iu s e dt oh a v ei tb u ti tw a s n ’tv e r y
good stuff, then I got poisoned. I thought I was taking
a m p h e t a m i n eb u tId o n ’tk n o ww h a ti tw a s ,a n di t
done something to me.” He explained how he knew
this had happened. “Because my muscles all felt
weird, it did something to my muscles, spasmed them
out. When I was 21 and it affected me for ten years
t h a t ,i tw a so n l y2 0 0 1t h a ti ta c t u a l l yw e n ta w a y ,I
knew it would go eventually but I needed good amphe-
tamine to get rid of it, that’sw h a tId i s c o v e r e d .
Because it took all my strength away and ampheta-
mine gave me strength so I was fighting against it all
the time. My muscles felt like someone had hold of my
arm all the time [he gestured as if being restrained]”.
When asked if he meant someone was not letting
him go, he continued. “Well no I could feel as if
someone had, that’s what it felt like, my muscles felt
like someone had hold, there was something wrapped
round my arm or someone touching me, a feeling all
the time on my arms and leg muscles. But I just kept
on persevering and kept on fighting it and kept walk-
ing and trying to get strong and trying to get strong
and then I’d be coming down [withdrawing], I’dh a v e
to get more amphetamines the next day and going
through ten years of doing that, and eventually I woke
up one day after doing a detox in hospital and in
prison and I realised “god it’s gone it’s gone”, I couldn’t
believe it” (Participant 13).
A man of African descent in his late forties who used
cannabis but had also used amphetamine in the past
explained:
“The problem with marijuana is you know it is not
the same all the time, it is rubbish most of the time
that is one of the problems. If you could standardise
you could decide, you could think better with it you
see, it’s changing all the time so it’s difficult to think
with it so [laughs] you know it’s difficult to think
with it”. (Participant 11).
T h i sm e a n tt h a th ek e p tu s i n gc a n n a b i si nt h eh o p e
that the next batch would be a ‘good’ one.
Participant 15, a white man in his twenties who had
used cannabis intermittently since age 15 and thought
he would continue to do so, said that cannabis “kills
[brain cells] off”, thus “over the years it could make you
lacking confidence”,a n dh et h o u g h ti tm a d eh i m“para-
noid“, meaning “People out to get you name calling you
behind your back and stuff. You just think they’re doing
it but maybe they’re not”.H o w e v e r ,c a n n a b i sw a sh i s
way of coping with voices and ‘paranoia’,i no r d e rt o
“relax, just forget about things“. He was well aware of
the contradiction and found this so stressful to discuss
that he terminated the interview.
Four people reported that they had had more unusual
experiences when they abstained from substances than
when they were using them. For instance this white
m a l ei nh i st h i r t i e sw h os t a r t e du s i n gc a n n a b i sa g e2 5
(following a bereavement and resultant family break-
down) began experiencing ‘pressure’ from voices soon
after:
“From the voices, just laughing as if they was, I mean
I was in a house where you couldn’t see in, but they
could, they was out there, “oh he’sd o i n gt h i sa n d
doing that and doing this and doing that” and then
having a giggle about it and I just lost it [became
mentally ill] and that was it then, I stopped smoking
completely, weed [cannabis] and normal cigs [cigar-
ettes].” (Participant 14).
W h e na s k e di fh et h o u g h tt h e r ew a sal i n kh es a i d .
“With the weed yeah, at first I did and then after about
a couple of weeks the voices got steadily and constantly
worse, even though I wasn’t using drugs whatsoever”
(Participant 14).
Many denied any dose-response relationship between
substance use and psychotic symptoms. Two considered
that voices were reduced by substances. Participant 11,
described above said that the effect of cannabis on
voices was “I think maybe keeps it quiet“,h o w e v e rh e
believed that the available cannabis “lacks potency“,
hence “it keeps it quiet but not as quiet as I think it can,
you know I don’tk n o wh o wq u i e ti tc a nk e e pi tb u tI
think it can keep it pretty quiet.” When asked what he
would have to do to cannabis to make the voices qui-
eter, he replied:
“You know if it if it has got the right potency because
cannabis is like apples, some apples are not so good,
some bananas are not so good, or for example aahh!
See cannabis is like that, so we have to learn how to
cultivate it, cannabis with ears that’s black, standar-
dise it like that” (Participant 11).
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est quantities to gain optimum effect:
“If I take about half a gram, or two half a gram a day,
it give me a feel good factor, I feel right again, I don’t
feel paranoid or anything. I’ve tried taking more than
that, but then it gets to me.” (Participant 5).
If too much of the substance was used, negative
effects could be experienced. Participant 4 (described
above), who regularly used cannabis, had been detained
in a psychiatric unit and said he had “escaped a few
days ago and had one joint” because he was craving
“just desperately wanted some”.C a n n a b i s“shouldn’tb e
done every day really” but “it can get that way though”,
in which case he can experience “short term memory
failure” and “that’s what you have to be careful of ”.H e
said that using cannabis once per three days was ideal
for him but “that would be very hard to stick to“ because
“it’s hard to get control over it” due to its being “psycho-
logically addictive”. (Participant 4). Like other intervie-
wees, he appeared to see substances as inherently
challenging, like mountain climbing, thus they could not
be fully mastered.
Many who did not regard hearing voices or other
unusual experiences as illness, did regard themselves as
having problems with mood or anxiety. Almost all
described using substances to treat mood, sleep, appe-
tite, or anxiety problems:
“It seemed like everybody knew that I were blessed
and everybody just wanted to pull me down, so that’s
when I started using drugs again.” (Participant 6).
Some also reported having improved functioning on a
limited dose of substances. A white male participant in
his twenties who used cannabis described the effects
“like a slight dose of hyperactivity“, he clarified “cannabis
makes you feel better“;a n d“lifts you mood as well“ and
“makes you more confident and makes you want a con-
versation more” (Participant 15). This phenomenon of
using a small amount of a substance to enable them to
carry out particular tasks has also been described earlier
in the ‘hopelessness’ theme.
Viewing illicit drug use as equivalent to taking
psychotropic medication
Many participants commented that prescribed medica-
tions were in many ways equivalent to illicit substances:
“...[cannabis is] a bit like when they give you medica-
tion, then it sometimes takes two week to kick in
[take effect]“. (Participant 6)
Participant 12 (described above) explained how she
used cannabis to avoid getting aggressive on the ward:
“Haloperidol takes about half an hour to work, now
i fy o un e e da ne m e r g e n c ys e d a t i o n ,i fy o u ’re going to
do any damage, you’r eg o i n gt od oi tb e f o r et h e
sedation works...Yeah, cannabis works within a few
minutes.” (Participant 12).
This meant that street drugs were useful instead of or
as an adjunct to prescribed medication. Ten thought
that health professionals were unfair or hypocritical for
saying that patients shouldn’t use substances, but should
use medication.
Participant 6 believed he would “get better” if he
used antipsychotic medication and cannabis in combi-
nation (although he would avoid mixing alcohol and
medication): “You’re better off just having a couple of
joints [cannabis cigarettes] and getting better that
way”. He also explained how he had used cannabis as
an inpatient:
“While I were in here cos I was slavering [dribbling
saliva], and just kept getting the slobbers [dribbles]
all the time, all over my top, it was horrible. So I
started smoking cannabis because cannabis gives
you dry mouth [laughs]. It worked too well, but they
weren’t too pleased, they took me off the cannabis
and gave me tablets instead, they weren’tt o o
pleased I’du s e di t .B u ti ts t o p p e dm ys l a v e r i n g .”
(Participant 6)
He believed that nurses didn’t want him to use canna-
bis because they didn’t like the fact that he had “solved
my problem of the dry mouth“ himself independently of
their control and because:
“What they were looking for was to see what the clo-
zapine were doing for me they didn’tw a n t ,i fIt a k e
cannabis it would have blocked it out you see and
they couldn’t have their study properly. Tell the doc-
tors and all that. They’ll think I were well, but really
it were I’d been having a few puffs of a joint [canna-
bis cigarette].” (Participant 6)
Participant 13 described above said that medication
was “bad”, he continued:
“I’ve been on it for quite a while, [yawns] years and it
doesn’ts e e mt od oa n y t h i n gf o rm eb e c a u s et h e
amphetamine just counteracts it and over-powers it.
It makes you look up like that sometimes [demon-
strates eyes rolling].”
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he said:
“Give you something like amphetamine does for me,
that’sw h yIf o u n dt h ed r u gt oc u r em ea n dt oh e l p
me: amphetamine. Whereas this stuff they give me,
depixol [antipsychotic depot], I don’tk n o ww h a ti t
does to you, I don’t feel any different”. (Participant 13)
Seven were intending to abstain in the future and five
o ft h e s es a i dt h a tt h e yg o tb e n e f i tf r o mt h e i rc u r r e n t
medication. For instance, an adolescent white male, who
had used cannabis since age 14, to join in with a delin-
quent group of peers, and had recently started using
cocaine, agreed to take his antipsychotics short term
and had ideas that using cannabis was part of returning
to normality, but by the end of the interview decided he
would quit for his 21
st birthday:
“Because I’ve been using it for so long and um it’s
been, I’ve been through a lot, I’ve been through mental
disease because of cannabis and I’ve been ‘schiz’,I
don’tk n o wi fi t s‘schiz’, something like ‘schiz’. But I’ve
b e e nt h r o u g hal o t ,t og i v ei tu pc o u l db eas t a n d i n g
point [good thing] for myself. Like saying, right I’ve
been through a lot, this has put me through a lot this
weed, put my family through a lot, I’mg o i n gt ok i c k
[stop using] it for good.” (Participant 10).
Conversely, ten intended to continue substance use in
future and out of these ten, only three said that pre-
scribed medication was helping them. Participants drew
comparisons between medication and illicit substances
as having in common the aim of altering mental state,
the one difference being whether or not the substance
was prescribed. In scrutinising prescribed medication in
this way, most found it was less useful or had worse
side effects than illicit substances. Rarely in this sample
did medication ameliorate voices, but participants
tended to complain instead about the effect of medica-
tion on their mood. There was rarely any expectation
that medication would influence voices, but despite this
some had complied with taking it, although there was
general suspicion of ‘treatment plans’.
Participant 17 described above explained how he had
used stimulants to overcome the side effects of antipsy-
chotic medication:
“Just the shaking and the way I was in myself, intro-
vert in myself, very light spoken. The reason I started
taking a lot of crack was because when I didn’t have
a stimulant in me I couldn’t be forceful, I couldn’t
put myself out, I couldn’t put myself across to people,
very ‘like that’ [whispering] because I didn’t have the
confidence it just dampened; when I was on depixol
[antipsychotic depot medication] it just stopped me,
it just zonked [sedated] me. It was like having a wall
in front of you every morning know with having to
get through that wall before I could get to living and
it was, oh it was horrible. Really, really horrible”.
(Participant 17).
Side effects were a common source of dissatisfaction
with medication. Some complained that medication was
given in hospital without proper explanation, which
seemed to reduce the credibility of the message of absti-
nence of professionals as well as damaging trust. Partici-
pants often considered themselves to be knowledgeable
about substances, such as awareness that similar percep-
tual abnormalities could occur with street drugs and medi-
cation, but felt that this was dismissed by professionals
“... mean a nurse can’t even explain that because
she’s never had drugs at all. She just knows that if
you take that for a while you’re going to get well.
Side effects, I talked to a young girl “don’t worry I
said, have you ever taken drugs?” she said “no” I
said, “this is what it’sl i k ew h e ny o ud od r u g st h i si s
how you feel” [snaps fingers] snapped out of it,
straight away"; (Participant 6)
Some accepted medical advice against using cannabis.
Others had agreed that street drugs may be harmful but
intended to continue using them. However, some saw
professionals as not having valid knowledge about drugs
and hence discredited their advice. First hand experience
of substances and symptoms was often thought of as
more valid than professional opinion. A white male in
his late 30 s, who regularly used cannabis to manage his
anxiety and feel more musical, had difficulty controlling
the frequency of use because cannabis was “psychologi-
cally addictive“. When the interviewer offered that she
had read that cannabis was also physically addictive as
evidenced by tolerance and withdrawals, he joked “so it’s
best to smoke it every day“(Participant 4).
Reasons for abstinence
Our study aimed to elicit factors that maintain illicit
drug use. However, 7 of the 17 participants reported a
current intention to maintain abstinence. Reasons
included disliking the effects and illegality of cannabis,
financial benefits of abstaining, increasing age (five of
the seven were age 35 years or over), physical health
problems and negative impact on mental state.
Four reported current family support and/or hope for
relationships if they abstained and five reported hoped
for or actual improved occupational/accommodation
status.
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bereavement, he had moved in with a relative, had a
change of medication to one with fewer side effects and
commenced voluntary work for a drugs service, thus he
had been abstinent for the last 2 years:
“Well I come from I look back at where I’ve been and
what I’ve done who I was then. it was a combination
of mental illness and the drugs, though it wasn’t just
the mental illness, it wasn’t just the drugs, it was the
combination of the two. it was the all the shit [bad]
that lies with being a junkie [drug addict] like the
stigma and how people look at you; kids coming up
[saying] “smack head [heroin addict]” and throwing
things at you. And you look like a tramp, you are a
tramp basically, not everyone, but I was anyway,
through the drugs, not eating. I’ve ate cat food. I’ve
lived on cat food you know eating tins of cat food on
bread, when I look at the person I was then, I’mn o t
today. where I’ve come and that’sw h a tk e e p sm e
going, it’s what keeps me off the drugs today, there’s
no way I’m going back there, I’mn o tg o i n gb a c kt o
that because with me I know for me anyway at least
with me, one’s too many and a million’s never
enough, I can’t just do one, it’s all or nothing really”.
(Participant 17)
Discussion
We have identified five interrelated factors that explain
the maintenance of drug misuse in people with a diag-
nosis of schizophrenia. It was striking that the intervie-
wees’ decisions to use or abstain from substances were
readily understandable when placed in the context of
their life experiences and beliefs. The relative impor-
tance of each of our five factors varied between partici-
pants, but they best explained the substance misuse
when taken together as headlines for the individual’s
stories.
Relevance to the literature
Other qualitative studies which investigated drug use in
people with psychotic disorders described as having a
‘severe mental illness’ are the COSMIC group study in
inner London predominantly from Black Minority Eth-
n i cg r o u p s[ 1 6 ] ,al a r g e rA m e r i c a ns t u d y[ 1 7 ]a n da
recent study of people in an early intervention service in
the UK [15]. The COSMIC study interviewed fewer par-
ticipants (14 participants), focussed primarily on drug
use rather than experience of symptoms and included
non specific psychosis and bipolar illness [16]. The USA
study included people with primary diagnosis of anxiety/
depression and people who did not use substances [17].
In the early intervention study, of the total sample of
19, several participants again appeared to have diagnoses
other than schizophrenia [15].
As in earlier studies [16] the factors associated with
onset of drug use in our study were consistent with
those of the general population - exposure to drugs and
influence of social networks [21]. Experience or knowl-
edge of drugs give the individual ‘social currency’ [16]
and a sense of belonging to a social network- a label of
‘drug user’ being preferable to that of mental illness
[22]. However mental health settings may actually pro-
vide a venue for accessing substances and forming social
networks with peers who use substances [9]. Our parti-
cipants also used drugs to relax, achieve a pleasurable
mental state and a sense of belonging [7,15,23] and our
findings confirm a hierarchy of acceptability of sub-
stances [15], with cannabis as the most acceptable.
However we also found that cannabis was perceived as a
means of avoiding ‘harder’ drugs, because peer pressure
could be assuaged and some intoxication achieved
through its use. In addition we found that in some
cases, pride in connoisseurship of substances (particu-
larly cannabis) maintained substance use.
Our results partly confirm the suggestion that people
who have schizophrenia may find it easier to develop
social networks with drug users, who may be more tol-
erant than other social groups and more accepting of
unusual personal attributes [24]. However, many of our
participants reported hiding some symptoms from drug-
using peers to avoid being labelled as ill.
A recent study [25] had shed doubt on the idea that
good pre-morbid functioning in schizophrenia increased
the risk of substance use [26]. Our findings concur with
Lobban et al. [15] in that drug use commonly started
with a group of peers but that all participants had some
current difficulty with socialising and that drugs were
used to alleviate this. This is consistent with studies
showing that street drugs are used to enable positive
social experiences and be accepted socially [16,27,28]
and improvements in social functioning lead to
decreased substance use [29].
A sub-group of people who have severe mental illness
and who feel alienated from conventional services and
society, use illicit substances, have unstable, impover-
ished social circumstances and see little chance of their
ever gaining employment [30]. Loss, rejection and being
exploited are experiences that can maintain or escalate
drug use [31]. Reducing or stopping drug use can be
m o t i v a t e db yac h a n g ei np e r s o n a ll i f eg o a l s[ 1 5 ] ,h o w -
ever, in our sample, there were examples of cycles of
unattainable goals, disappointment and relapsing to
drug use to cope with such feelings. It was difficult to
establish why they had settled upon such goals, as any
challenge to these seemed to threaten rapport during
the interviews. However it seemed that they did not
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entitled to better, but they were outside of and thus
unable to learn from any culture of working steadily
towards realistic goals. In addition, we found drugs were
sometimes used to reminisce about happier times. Thus
our study highlights the long term challenge of main-
taining any reduction in drug use.
Previous studies have found good evidence that clients
with schizophrenia use substances to self medicate for
tension, low mood, anxiety and negative symptoms
[6,10,15,16,27] as did we. However studies of whether or
not self-medication occurs for positive symptoms have
revealed mixed results [10,16]. This may reflect differ-
ences in methodology. We found that some patients
were aware of adverse effects of drugs on positive symp-
toms [16,22,20] but that substance use did not exacer-
bate positive symptoms in all individuals [1,15,20,32].
However we found that a particular client may regard
some symptoms as being illness (such as depressed
mood) and others as being real (such as voices) and
they may be unwilling to give up substances that
increase certain symptoms because of a reliance upon
anxiolytic effects of substances, for instance to cope
with hearing voices. Hence participants could see them-
selves as using drugs to cope with the stress of ‘real’
persecution. Unlike in other qualitative studies we also
did identify cases of use of drugs with the aim of redu-
cing hearing voices, (note that this did not necessarily
involve the participant viewing the voices as being due
to any kind of illness).
Participants told us that street drugs had to be used at
optimal doses to achieve beneficial effects on mood and
to avoid ‘paranoia’. Our results concurred with previous
qualitative research [15] that personal experience of sub-
stance use effects and the temporal sequence of events
were given more credibility than professional opinion
about influence of drugs on a person’s mental state. In
our study, participants also said that there was an opti-
mal dose but admitted that it was difficult to not esca-
late the dose of street drugs, to their detriment.
Therefore, cutting down may sometimes be a more rea-
listic goal than abstinence. Difficulty was encountered in
adhering to the optimal dose of the chosen substance
despite participants often perceiving themselves to be
experts in that drug, the drugs themselves seemed to be
seen as inherently challenging and slips were a part of
an explorer’s experience, as if they were mountain clim-
bers. Tactful discussion of such proneness to slips could
be put to therapeutic use with patients.
We also found that some participants were using sti-
mulants to enable them to engage in activities, this may
be a vicious circle as cocaine has been shown to
increase extra-pyramidal side effects of antipsychotics
[33] and some patients did cite extra-pyramidal side
effects as a reason for drug use [16]. Patients may also
view illicit drugs as more efficacious against subjective
distress than prescribed drugs [34-36]. We found that
professionals may be seen as hypocritical and controlling
for discouraging street drug use whilst insisting on med-
ication compliance. The implication of this finding is
that a non-collaborative approach to pharmacotherapy
may result in street drug-taking that is in part a rebel-
lion against the clinician.
Some participants suggested that they used cannabis in
the hope of reducing their voices as they had intermit-
tently had this effect in the past. Intriguingly, cannabidiol
reduces the effect of THC, the main hallucinogenic con-
stituent of cannabis; cannabidiol has antipsychotic prop-
erties [37], but the THC content is increased and the
cannabidiol content is reduced in currently available
street cannabis compared to ten years ago [7]. Could it
be that patients previously found benefit from higher
cannabidiol content cannabis and are still using cannabis
on that basis?
Some participants reported street drugs to focus their
attention more on persecutory voices in the hope of
outwitting their perceived persecutors. The phenomenon
of using drugs to increase voices had been noted in a
previous study [18] and our study has confirmed and
elaborated this finding.
Finally, our results also offer some support for the
hypothesis that a common factor may simultaneously
increase the risk of drug use and of schizophrenia [6].
Many participants spoke of childhood adversity, includ-
ing early traumatic experiences, family dysfunction,
deprivation and poor educational attainment, all of
which have been linked with both schizophrenia and
substance use disorders [6].
Strengths and limitations
We have presented our findings to a group of service
users who validated the themes that we identified. To
our knowledge, this study is unique in using qualitative
analysis of interviews to investigate reasons for on-going
drugs use in people who all have a clinical diagnosis of
schizophrenia. Previous studies with mixed populations
have left doubts as to whether the themes identified
applied to people with schizophrenia. We assert that we
have clarified and expanded our knowledge of reasons
for drug use in people with schizophrenia and therefore
demonstrated the usefulness of qualitative research in
this subject area.
We accept that the sample size in this study was
small, but saturation of themes was achieved in the ana-
lysis. Another limitation must however be the low num-
bers of ethnic minority and female participants that we
succeeded in recruiting. While it is not suggested that
the specific results are generalisable to all populations,
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people with a diagnosis of schizophrenia who use drugs
may commonly hold and the explanations they might
have for these views.
Our study did not specifically assess for research diag-
nostic criteria for a diagnosis of schizophrenia, clinical
or research criteria of drug dependence or for presence
of co-morbid personality disorder.
Reflexivity
The first author carried out all of the interviews and
may have become progressively more attuned to the
participants’ stories as the data collection went along.
The first author informed all participants of her job
title but then encouraged use of her first name and
adopted a friendly and ‘curious’ stance. This was to
avoid non-disclosure of data due to thinking that she
would disapprove. However, when participants seemed
to be strongly talking themselves into increased drug
use, for ethical reasons, the interviewer tended to
encourage balancing this against ‘less good things’ they
could identify about drug use. Both authors are psy-
chiatrists, so in analysing the data and so we would
tend to see medical symptom clusters, such as anxiety
and depression, amongst the reasons given for street
drug use.
Conclusions
The use of qualitative methods in dual diagnosis
research is supported. This study has identified novel
factors that maintain drug use in schizophrenia, as well
as usefully confirming some of the findings of recent
qualitative research with people with ‘psychosis’.F a m i l -
iarity with our five themes generated from this study
could improve the mental health professional’s clinical
assessment of dual diagnosis patients, in terms of gath-
ering more pertinent information and being sensitive to
the client’s perspective in collaborating formulating a
management plan. Further studies are warranted to eval-
uate standardised methods of assessing patients for the
presence and relative importance of the five reasons for
continuing drug use identified in our study, with a view
to improving outcomes for this population.
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